-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JeSFLCGxQDCPwC2484bn1ekPbhNKIrcxzs7KZGoiifFJYrLD4Hq31DMmm9Q+lAPT awm5yd6kCoadeasvep0cWA== 0001266375-06-000082.txt : 20060803 0001266375-06-000082.hdr.sgml : 20060803 20060803161103 ACCESSION NUMBER: 0001266375-06-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060801 FILED AS OF DATE: 20060803 DATE AS OF CHANGE: 20060803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MADDON PAUL J CENTRAL INDEX KEY: 0001250313 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 061002175 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-08-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250313 MADDON PAUL J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 1 0 Chief Executive Officer/CSO Common Stock 2006-08-01 4 M 0 5000 5.33 A 645828 D Common Stock 2006-08-01 4 S 0 5000 21.54 D 640828 D Common Stock 2006-08-01 4 M 0 7000 5.33 A 647828 D Common Stock 2006-08-01 4 S 0 7000 21.6 D 640828 D Non-Qualified Stock Option (right to buy) 5.33 2006-08-01 4 M 0 5000 0 D 1997-12-15 2007-12-16 Common Stock 5000 346000 D Non-Qualified Stock Option (right to buy) 5.33 2006-08-01 4 M 0 7000 0 D 1997-12-15 2007-12-16 Common Stock 7000 339000 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer. The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer. Paul J. Maddon 2006-08-03 -----END PRIVACY-ENHANCED MESSAGE-----